References
- Moroni G, Depetri F, Ponticelli C. Lupus nephritis: when and how often to biopsy and what does it mean? J Autoimmun. 2016;74:27–40.
- Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521–530.
- Austin HA, 3rd, Muenz LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984;25:689–695.
- Baranowska-Daca E, Choi YJ, Barrios R, et al. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Hum Pathol. 2001;32:1125–1135.
- Anders HJ, Weening JJ. Kidney disease in lupus is not always ‘lupus nephritis’. Arthritis Res Ther. 2013;15:108.
- Herrera GA. The value of electron microscopy in the diagnosis and clinical management of lupus nephritis. Ultrastruct Pathol. 1999;23:63–77.
- Silvarino R, Sant F, Espinosa G, et al. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus 2011;20:721–729.
- Appel GB, Pirani CL, D’Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol. 1994;4:1499–1515.
- Song D, Wu LH, Wang FM, et al. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther. 2013;15:R12.
- Howell DN, Gu X, Herrera GA. Organized deposits in the kidney and look-alikes. Ultrastruct Pathol. 2003;27:295–312.
- Abdellatif AA, Waris S, Lakhani A, et al. True vasculitis in lupus nephritis. Clin Nephrol. 2010;74:106–112.
- Hu W, Chen Y, Wang S, et al. Clinical-morphological features and outcomes of lupus podocytopathy. Clin J Am Soc Nephrol. 2016;11:585–592.
- Haas M. Collapsing glomerulopathy in systemic lupus erythematosus: an extreme form of lupus podocytopathy? Clin J Am Soc Nephrol. 2012;7:878–880.
- Salvatore SP, Barisoni LM, Herzenberg AM, et al. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol. 2012;7:914–925.
- Joh K, Taguchi T, Shigematsu H, et al. Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan. Clin Exp Nephrol. 2008;12:421–431.
- Jarrot PA, Chiche L, Hervier B, et al. Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis. Medicine (Baltimore) 2016;95:e3748.
- Li CH, Li YC, Xu PS, et al. Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis. Scand J Rheumatol. 2006;35:201–208.
- da Silva LS, Almeida BL, de Melo AK, et al. IgA nephropathy in systemic lupus erythematosus patients: case report and literature review. Rev Bras Reumatol Engl Ed. 2016;56:270–273.
- Larsen CP, Messias NC, Silva FG, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26:709–715.
- Bhat ZY, Zeng X, Hingorani J, et al. Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association. Int Urol Nephrol. 2013;45:281–284.
- Oeser A, Chung CP, Asanuma Y, et al. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum. 2005;52:3651–3659.
- D’Agati V, Schmidt AM. RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol. 2010;6:352–360.
- Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–1509.
- Sethi S, Vrana JA, Theis JD, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012;82:226–234.